Bone Metastases of Urothelial Carcinoma

Department of Urology, Ibn Rochd University Hospital, Morocco

*Corresponding Author: Dr. Safwate Reda, Department of Urology, Ibn Rochd University Hospital and Faculty of Medicine and Pharmacy, Casablanca, Morocco, Tel: +212662097858, Email: [email protected]

Received Date: March 19, 2025

Published Date: April 10, 2025

Citation: Reda S, et al. (2025). Bone Metastases of Urothelial Carcinoma. Mathews J Case Rep. 10(2):204.

Copyrights: Reda S, et al. © (2025).

ABSTRACT

Background: Bone metastases of urothelial carcinoma are the third most common metastasis after the lungs and liver. Bone complications adversely affect quality of life. They are also associated with increased mortality. The objective of this study is to describe the epidemiological, clinical and prognostic aspects of bone metastases of urothelial carcinoma. Material and methods: This is a retrospective, monocentric study of 8 cases of bone metastases of urothelial carcinoma, collected from January 2022 to December 2024 at the Ibn Rochd University Hospital in Casablanca, Morocco. The analyzed data were collected on an exploitation sheet. Incomplete records were excluded from the study. Results: The average age of our patients was 61.37 years. All patients were male and smokers. Pain was the main calling sign and was found in seven patients. Four patients had anemia and 50% of the patients had acute obstructive kidney disease. All patients had undergone a CT scan that confirmed bone metastases in seven patients with predominantly osteolytic lesions. Treatment was palliative and consisted of chemotherapy, radiotherapy or a combination of both. Three patients died, two progressed with new lesions. Three had stabilized lesions. Conclusion: The presence of bone metastases of urothelial carcinoma constitutes an unfavorable moment in the evolution of this cancer. These metastases are responsible for numerous complications that require multidisciplinary management.

Keywords: Urothelial Carcinoma, Bone Metastases, Thoracoabdominopelvic Scanner.